These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 28438150
21. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate. Cheng PT, Chan C, Müller K. J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618 [Abstract] [Full Text] [Related]
23. Effect of intermittent administration of human parathyroid hormone (1-34) on the mandibular condyle of ovariectomized rats. Nakajima M, Ejiri S, Tanaka M, Toyooka E, Kohno S, Ozawa H. J Bone Miner Metab; 2000 Jan; 18(1):9-17. PubMed ID: 10633271 [Abstract] [Full Text] [Related]
24. Distributional variations in trabecular architecture of the mandibular bone: an in vivo micro-CT analysis in rats. Liu Z, Yan C, Kang C, Zhang B, Li Y. PLoS One; 2015 Jan; 10(1):e0116194. PubMed ID: 25625431 [Abstract] [Full Text] [Related]
25. Microarchitectural changes in the mandibles of ovariectomized rats: a systematic review and meta-analysis. Lee JH, Han SS, Lee C, Kim YH, Battulga B. BMC Oral Health; 2019 Jun 26; 19(1):128. PubMed ID: 31242880 [Abstract] [Full Text] [Related]
26. Cone-Beam Computed Tomography to evaluate changes in trabecular lower jawbone microstructure caused by bone loss and antiresorptive treatment. Avendano ME, Bonanno MS, Zeni Coronel EM, Marotte C, Zeni SN, Davison MR. Acta Odontol Latinoam; 2023 Dec 31; 36(3):131-139. PubMed ID: 38345274 [Abstract] [Full Text] [Related]
27. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE. J Bone Miner Res; 2009 Feb 31; 24(2):209-20. PubMed ID: 18847326 [Abstract] [Full Text] [Related]
28. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass. Amugongo SK, Yao W, Jia J, Lay YA, Dai W, Jiang L, Walsh D, Li CS, Dave NK, Olivera D, Panganiban B, Ritchie RO, Lane NE. Osteoporos Int; 2014 Jun 31; 25(6):1735-50. PubMed ID: 24722767 [Abstract] [Full Text] [Related]
29. Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus. Liu GY, Cao GL, Tian FM, Song HP, Yuan LL, Geng LD, Zheng ZY, Zhang L. Osteoporos Int; 2017 Oct 31; 28(10):3043-3053. PubMed ID: 28808745 [Abstract] [Full Text] [Related]
32. The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat. Campbell GM, Bernhardt R, Scharnweber D, Boyd SK. Bone; 2011 Aug 31; 49(2):225-32. PubMed ID: 21515436 [Abstract] [Full Text] [Related]
33. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats. Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L. Injury; 2015 Nov 31; 46(11):2164-9. PubMed ID: 26404665 [Abstract] [Full Text] [Related]
35. Bone microarchitectural parameters can detect oxytocin induced changes prior to bone density on mitigating bone deterioration in rabbit osteoporosis model using micro-CT. Qiu Y, Tang C, Serrano-Sosa M, Hu J, Zhu J, Tang G, Huang C, Huang M. BMC Musculoskelet Disord; 2019 Nov 23; 20(1):560. PubMed ID: 31759393 [Abstract] [Full Text] [Related]
37. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY. Calcif Tissue Int; 2006 Oct 23; 79(4):262-72. PubMed ID: 16969596 [Abstract] [Full Text] [Related]